One third of Americans have at least one symptom of insomnia every or most nights—a problem that may only have gotten worse with the advent of COVID-19. Since the beginning of the pandemic, higher rates of insomnia, depression, and anxiety have been reported in essential workers and in the general population. In this case-based activity, a sleep expert reviews how to do a thorough workup for insomnia, comorbidities to consider, how to determine the specific type of insomnia, and the roles of various therapies—including sleep hygiene measures, cognitive behavioral therapy, traditional pharmacologic agents, and the newer dual orexin receptor antagonists.
Interactive case study
After completing this activity, participants should be better able to:
- Screen patients for insomnia according to current diagnostic criteria
- Identify the cause of insomnia, including psychosocial and lifestyle issues and comorbidities, to determine treatment and reduce risk factors
- Individualize treatment with approved insomnia medications, including dual orexin receptor antagonists
NPs and PAs
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
CNE course advisor: Mary Knudtson, DNSc, NP, FAAN, University of California, Irvine, Irvine, California
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until March 30, 2022. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Lawrence Herman, DMSc, MPA, PA-C, University of Lynchburg, Lynchburg, Virginia
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity was developed from a series of programs cosupported by educational grants from Bristol-Myers Squibb; Genentech, a member of the Roche Group; Gilead Sciences, Inc.; Eisai; and Novo Nordisk Inc.
This activity is supported by an educational grant from Eisai.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Neubauer: consultant: Abbott Laboratories, Eisai.
Dr Herman: consultant/speakers bureau: Novo Nordisk.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose, except Dr Herman as noted above.
Participants wishing to earn CE/CME credit must:
- Read the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 67%.
The estimated time to complete this activity is 1.00 hour.
Release date: March 31, 2021
Expiration date: March 30, 2022
© 2021 Practicing Clinicians Exchange. All Rights Reserved. 97320C-7A